30 Day Trial

FDA Approves Update of Mobi-C Cervical Disc Labeling to Include 5-Year Clinical Results


FDA approved an update to the labeling for LDR's Mobi-C® Cervical Disc to include 5-year clinical results. The updated data is consistent with previous findings at 24 months, that at 60 months of follow-up, Mobi-C is statistically non-inferior in overall study success for 1-level use and statistically superior in terms of overall study success for 2-level use.

Mobi-C is a cobalt chromium alloy and polyethylene mobile-bearing prosthesis designed as a bone-sparing, cervical intervertebral disc replacement, and is the only FDA-approved disc for 1-level and 2-level use.

Source: LDR Holding Corporation